ORONASAL CBD FORMULATIONS AND USES THEREOF
Last updated:
Abstract:
Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
Status:
Application
Type:
Utility
Filling date:
21 Jun 2021
Issue date:
23 Dec 2021